REMINDER: Our user survey closes on Friday, please submit your responses here.
@Stampee1 I was completely put off this company when the SP was hovering around 3.3p and they did raise priced at 2.25p (retail investors were excluded) eventually causing the SP to crash to 1p. Seems more like a gravy train.
I'll take your word for it, remember him saying something about Autumn.
@Sanji I remember Alex saying they would release the data when they had 10 people in each of the main 3 cohorts. Are you sure he specifically said October?
I don't think anything's changed Phil. Just a bounce from 89p and then sheeple buying into a pump and dump.
It's the auction uncrossing trade.
Wonder if it's related to the 395,000 trade at 5:05 PM today.
The last Merck CEO was asked about takeovers. I've no opinion on the likelihood of a takeover but this is quite a good article:
https://www.fiercepharma.com/pharma/jpm-merck-not-complacent-but-we-re-not-desperate-for-deals-ceo-says
Be careful guys, seeing a lot of NASDAQ traders doubling their positions on the big market drop today.
Only gamble what you can afford to lose. Good luck.
@MarkP1989 I've seen that sort of thing in other Pharma shares on the NASDAQ. If you go to the NASDAQ website, it will give you a list of after-hours or pre-market trades.
Usually there is something like a buy/sell of a single share at a silly price to create what you see there.
It relates back to the merger, how strange.
I haven't heard about that Sangi, thanks for the heads-up.
I have no plans to convert my shares anyway.
Yes Panderman, it's just really just to let people know that they can convert their shares across if the NASDAQ price ever gets ahead of the AIM price.
It could also be an indication that 4D might delist from AIM in a year or two which would be a good thing in my opinion.
@sunnyca It's $5 per 100 ADS, which is equivalent to 800 AIM shares.
So, I calculate it as $500 to convert 80,000 AIM shares after the March 2022 deadline.
Let me know if I've got this wrong, it's bit early in the morning for arithmetic.
@Sangi The whole sector should benefit from the first approval, big pharma will be scrambling to pick up the companies with the best IP portfolios.
I took the plunge and bought into Synlogic, market cap is $140m. That's got to be a good bet.
Not sure if people have seen this one. It's a long conference call with 4D Pharma, Synlogic and BiomX.
https://us02web.zoom.us/rec/play/OSbT-xcCaG4Ek2X74SCfa1lVXt7WaF2QnimU2WnoK2EQDEDXjDpkWTj2OnhIJqDKkV27FO0gJgUnZsVM.7YiQvc11XX--hQHw?continueMode=true&_x_zm_rtaid=Rpg9w_4jQpqxFbl-J5OjeQ.1617200362951.c96e4c6e9edcf9344768bddcef06deba&_x_zm_rhtaid=203
I'm not going to start singling people out, I just wanted to draw attention to some manipulation going on.
So people are aware, the hedge funds are busy posting negative comments on this board. They want to drive down the share price by scaring people into selling.
There's one guy who has copied and pasted the same comment to LSE, ADVFN and Twitter.
@Junior2020 Hedge funds are shorting.
LBPS is showing price of $11.66, equivalent to £1.05.
Someone on this board said that 4D Pharma told them they could convert their AIM shares to US ADRs by contacting their broker. I've never verified if that's true.